Skip navigation

Disease mongering, part 2

It s interesting to see two items related to this show up in one day (see below). In this one, the International Network of Cholesterol Skeptics take issue with the recently revised cholesterol-lowering guidelines, saying they will "result in millions more people being placed on statins" putting them at risk for side effects unnecessarily."

Among those the group accuses of helping "hype" statins are "medical opinion leaders who have, unfortunately, become little more than paid advertorials." While the ACCME Standards for Commercial Support and Essential Areas and Their Elements should eliminate this perception of bias for ACCME-accredited activities, obviously there is still a perception out there that faculty are little more than paid shills for the drug companies.

What can this industry do to change that perception once and for all?

To receive a weekly update, e-mail Sue.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.